GPHA responds to choice of Michael Froman as U.S. trade representative

Generic drug lobby looks forward to working with Froman

WASHINGTON — A White House trade policy leader has been appointed as U.S. trade representative.

The Senate voted last week to approve Michael Froman to the position. Froman was previously an adviser to President Barack Obama on international economic affairs and replaces acting U.S. Trade Representative Miriam Sapiro.

The Generic Pharmaceutical Association, a trade group for the generic drug industry, said it looked forward to working with Froman in negotiations such as the Trans-Pacific Partnership, a free-trade program that includes Japan and 10 other countries in the Asia-Pacific region. The GPhA said such agreements would open markets to U.S.-made generic drugs.

"As U.S.T.R., I intend to use every tool to increase exports of made-in-America goods and services, level the playing field for our people to compete and win in the global economy and fully enforce our trade rights, while also working to foster development through trade," Froman said at his swearing-in ceremony.


Login or Register to post a comment.